P. Heinke

发表

Associations of blood glucose dynamics with antihyperglycemic treatment and glycemic variability in type 1 and type 2 diabetes

K. Kohnert, P. Heinke, L. Vogt, 2017, Journal of Endocrinological Investigation.

Telemedicine-Based KADIS® Combined with CGMS™ Has High Potential for Improving Outpatient Diabetes Care

K. Kohnert, P. Heinke, L. Vogt, 2007, Journal of diabetes science and technology.

Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors

K. Kohnert, P. Heinke, W. Kerner, 2000, The British journal of ophthalmology.

Glycemic Variability Strongly Correlates with Postprandial ß-cell Dysfunction in a Segment of Type 2 Diabetic Patients Using Oral Hypoglycemic Agents

R. Hovorka, K. Kohnert, P. Heinke, 2009 .

Translation of Personalized Decision Support into Routine Diabetes Care

Eckhard Salzsieder, Petra Augstein, Peter Heinke, 2010, Journal of diabetes science and technology.

Applications of Variability Analysis Techniques for Continuous Glucose Monitoring Derived Time Series in Diabetic Patients

K. Kohnert, P. Heinke, L. Vogt, 2018, Front. Physiol..

, 1 and type 2 : associations with risk factors Maculopathy in patients with diabetes mellitus type

K. Kohnert, P. Heinke, W. Kerner, 2000 .

Author's response to reviews Title:Q-Score: Development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies Authors:

P. Heinke, P. Augstein, C. Rackow, 2015 .

Relationships between glucose variability and conventional measures of glycemic control in continuously monitored patients with type 2 diabetes.

K. Kohnert, P. Heinke, L. Vogt, 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Fas ligand down-regulates cytokine-induced Fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice.

P. Heinke, P. Augstein, E. Salzsieder, 2004, Endocrinology.

Importance of Cardiovascular Autonomic Dysfunction in IDDM Subjects With Diabetic Nephropathy

P. Heinke, B. Schulz, E. Zander, 1989, Diabetes Care.

Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes

P. Heinke, K. Ratzmann, B. Schulz, 1984, Diabetologia.

Primary health care of diabetic patients in a specialized outpatient setting: a DIABCARE-based analysis.

P. Heinke, L. Vogt, E. Salzsieder, 1993, Diabete & metabolisme.

Dominance of cytokine- over FasL-induced impairment of the mitochondrial transmembrane potential (ΔΨm) in the pancreatic β-cell line NIT-1

P. Heinke, P. Augstein, E. Salzsieder, 2008, Diabetes & vascular disease research.

Characterization of the Human Pancreas Side Population as a Potential Reservoir of Adult Stem Cells

A. M. Neale, P. Heinke, P. Augstein, 2017, Pancreas.

Relationship between body fat mass, carbohydrate tolerance and iri response during glucose infusion in subjects with early diabetes

P. Heinke, K. Ratzmann, B. Schulz, 2007, Acta diabetologia latina.

and fibrinogen synthesis in young healthy volunteers Effects of fatty acids on hepatic amino acid catabolism

P. Heinke, C. Metges, K. Petzke, 2016 .

Pancreatic glucagon response to glucose in hyperlipoproteinaemia with and without abnormalities in carbohydrate metabolism.

P. Heinke, M. Ziegler, K. Ratzmann, 1980, Acta endocrinologica.

Increased prevalence of proliferative retinopathy and cardiovascular autonomic dysfunction in IDDM patients with proteinuria.

P. Heinke, R. Chlup, S. Herfurth, 2009, Experimental and clinical endocrinology.

Surface and intracellular Fas expression associated with cytokine-induced apoptosis in rodent islet and insulinoma cells.

P. Heinke, P. Augstein, E. Salzsieder, 2003, Journal of molecular endocrinology.

Cell surface trafficking of Fas in NIT-1 cells and dissection of surface and total Fas expression.

P. Heinke, P. Augstein, E. Salzsieder, 2002, Biochemical and biophysical research communications.

Model-Based Tool for Personalized Adjustment of Basal Insulin Supply in Patients With Intensified Conventional Insulin Therapy

K. Kohnert, P. Heinke, L. Vogt, 2019, Journal of diabetes science and technology.

DPP-4 inhibition increases GIP and decreases GLP-1 incretin effects during intravenous glucose tolerance test in Wistar rats

K. Kohnert, P. Heinke, E. Salzsieder, 2011, Biological chemistry.

The effect of ageing on insulin sensitivity and insulin secretion in non-obese healthy subjects.

P. Heinke, K. Ratzmann, B. Schulz, 1982, Acta endocrinologica.

Glycemic Key Metrics and the Risk of Diabetes-Associated Complications

K. Kohnert, P. Heinke, L. Vogt, 2016 .

Improvement of glucose tolerance in Zucker diabetic fatty rats by long‐term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone

T. Hoffmann, P. Heinke, P. Augstein, 2005, Diabetes, obesity & metabolism.

Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes.

K. Kohnert, P. Heinke, P. Augstein, 2007, Diabetes research and clinical practice.

Quantitative and qualitative changes in the early insulin response to glucose in subjects with impaired carbohydrate tolerance

P. Heinke, K. Ratzmann, B. Schulz, 1981, Diabetes Care.

Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.

P. Heinke, P. Augstein, E. Salzsieder, 2004, Journal of autoimmunity.

The higher frequency of type I (insulin-dependent) diabetes in fathers than in mothers of type I-diabetic children.

P. Heinke, I. Rjasanowski, D. Michaelis, 2009, Experimental and clinical endocrinology.

5-year follow-up study of C-peptide secretion in newly diagnosed type I diabetics: relations to HLA-phenotype, insulin requirement and metabolic control.

P. Heinke, W. Besch, H. Keilacker, 2009, Experimental and clinical endocrinology.

Patient-Tailored Decision Support System Improves Short- and Long-Term Glycemic Control in Type 2 Diabetes

K. Kohnert, P. Heinke, L. Vogt, 2021, Journal of diabetes science and technology.

Peripheral arterial disease in diabetes mellitus type 1 and type 2: are there different risk factors?

K. Kohnert, P. Heinke, W. Kerner, 2002, VASA. Zeitschrift fur Gefasskrankheiten.

Regulation of pancreatic glucagon secretion during a continuous glucose infusion in early and overt diabetics.

P. Heinke, M. Ziegler, B. Schulz, 1978, Acta endocrinologica.

Use of the KADIS-CSII program for adjusting insulin pump therapy in type 1 diabetes

K. Kohnert, P. Heinke, L. Vogt, 2016 .

Localization of dipeptidyl peptidase-4 (CD26) to human pancreatic ducts and islet alpha cells.

K. Rogers, P. Heinke, P. Augstein, 2015, Diabetes research and clinical practice.

Insulin and glucagon secretion and the insulin sensitivity of peripheric organs of colony-bred sand rats fed with pellet diet after weaning.

P. Heinke, H. Hahn, H. Schäfer, 1977, Endokrinologie.

Outpatient assessment of KADIS ® –based decision support

K. Kohnert, P. Heinke, L. Vogt, 2007 .

A stimulatory effect of tolbutamide on the insulin-mediated glucose uptake in subjects with impaired glucose tolerance (IGT).

P. Heinke, K. Ratzmann, B. Schulz, 2009, Experimental and clinical endocrinology.

IL-1β, IFN-γ and TNF-α increase vulnerability of pancreatic beta cells to autoimmune destruction

P. Heinke, P. Augstein, I. Klöting, 2003 .

Titre determination of autoantibodies (ICSA) against beta cell surface antigens

P. Heinke, M. Ziegler, B. Ziegler, 1988 .

In vitro pancreatic B-cell response of hyperinsulinemic rats. Differences between pregnancy and VMH-lesions

P. Heinke, H. Hahn, W. Besch, 1983, Acta diabetologia latina.

A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor‐1α (HNF‐1α) gene

P. Heinke, W. Kerner, P. Kaisaki, 1998 .

Estimation of pancreatic IRI output rate and its relation to glucose tolerance in normal anaesthetized dogs

P. Heinke, U. Fischer, P. Heinke, 1975, Diabetologia.

Incidence of Type 1 Diabetes in Childhood before and after the Reunification of Germany – an Analysis of Epidemiological Data, 1960–2006

K. Dietz, P. Heinke, A. Neu, 2012, Experimental and Clinical Endocrinology & Diabetes (Barth).

Efficacy of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide (P32/98) in fatty Zucker rats with incipient and manifest impaired glucose tolerance

P. Heinke, P. Augstein, E. Salzsieder, 2008, Diabetes, obesity & metabolism.

Effects of fatty acids on hepatic amino acid catabolism and fibrinogen synthesis in young healthy volunteers.

P. Heinke, C. Metges, K. Petzke, 2003, American journal of physiology. Endocrinology and metabolism.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Reduced Glucose Variability Is Associated With Improved Quality of Glycemic Control in Patients With Type 2 Diabetes: A 12-Month Observational Study

K. Kohnert, P. Heinke, L. Vogt, 2011 .

Utility of different glycemic control metrics for optimizing management of diabetes.

Eckhard Salzsieder, Peter Heinke, Lutz Vogt, 2015, World journal of diabetes.

Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.

P. Heinke, P. Augstein, E. Salzsieder, 2003, Biochemical and biophysical research communications.

IL-1beta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction.

P. Heinke, P. Augstein, I. Klöting, 2003, Journal of autoimmunity.

Evaluation of the mean absolute glucose change as a measure of glycemic variability using continuous glucose monitoring data.

Eckhard Salzsieder, Petra Augstein, Peter Heinke, 2013, Diabetes technology & therapeutics.

The use of a computer program to calculate the mean amplitude of glycemic excursions.

Eckhard Salzsieder, Peter Heinke, Lutz Vogt, 2011, Diabetes technology & therapeutics.

Declining ß-cell function is associated with the lack of long-range negative correlation in glucose dynamics and increased glycemic variability: A retrospective analysis in patients with type 2 diabetes*

K. Kohnert, P. Heinke, L. Vogt, 2014, Journal of clinical & translational endocrinology.

Glycemic Variability Correlates Strongly With Postprandialβ-Cell Dysfunction in a Segment of Type 2 Diabetic Patients Using Oral Hypoglycemic Agents

R. Hovorka, K. Kohnert, P. Heinke, 2009, Diabetes Care.

Model-based Decision support in Diabetes Care

E. Salzsieder, L. Vogt, K.-D. Kohnert, 2011, Comput. Methods Programs Biomed..

Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies

Eckhard Salzsieder, Petra Augstein, Peter Heinke, 2015, BMC Endocrine Disorders.

A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene.

P. Heinke, S. Menzel, W. Kerner, 1998, Diabetic medicine : a journal of the British Diabetic Association.

Incidence trends of type 1 diabetes before and after the reunification in children up to 14 years of age in Saxony, Eastern Germany

J. Hegewald, P. Heinke, E. Salzsieder, 2017, PloS one.

[Relation of uteroplacental circulation and morphologic findings in myometrial and decidual arteries in diabetic pregnancy].

P. Heinke, K. Fuhrmann, K. Semmler, 1985, Zentralblatt fur Gynakologie.

Metabolisches Syndrom bei Patienten mit Diabetes mellitus Typ 1

K. Kohnert, P. Heinke, W. Kerner, 2004, Herz.

[The metabolic syndrome in patients with type 1 diabetes mellitus. Associations with cardiovascular risk factors and cardiovascular morbidity].

K. Kohnert, P. Heinke, W. Kerner, 2004, Herz.

Pharmacokinetics and Biological Activity of the New Intermediate-Acting Insulin L-SNC1)

P. Heinke, B. Schulz, R. Menzel, 1987, Experimental and clinical endocrinology.